Financial Services
Build Your Comparison
Side-by-side financial analysisStock Comparison
VACHU vs JPM vs GS vs MS
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Diversified
Financial - Capital Markets
Financial - Capital Markets
VACHU vs JPM vs GS vs MS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Financial Services | Banks - Diversified | Financial - Capital Markets | Financial - Capital Markets |
| Market Cap | $508M | $896.00B | $337.53B | $340.97B |
| Revenue (TTM) | $0.00 | $280.33B | $125.10B | $114.98B |
| Net Income (TTM) | $7M | $57.05B | $17.18B | $16.86B |
| Gross Margin | — | 60.0% | 47.5% | 57.1% |
| Operating Margin | — | 25.9% | 17.5% | 19.1% |
| Forward P/E | 43.1x | 14.4x | 17.9x | 18.0x |
| Total Debt | $0.00 | $942.38B | $609.53B | $475.56B |
| Cash & Equiv. | $182K | $343.34B | $164.26B | $111.69B |
VACHU vs JPM vs GS vs MS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 24 | Jun 26 | Return |
|---|---|---|---|
| Voyager Acquisition… (VACHU) | 100 | 155.3 | +55.3% |
| JPMorgan Chase & Co. (JPM) | 100 | 133.1 | +33.1% |
| The Goldman Sachs G… (GS) | 100 | 201.0 | +101.0% |
| Morgan Stanley (MS) | 100 | 200.8 | +100.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VACHU vs JPM vs GS vs MS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VACHU is the clearest fit if your priority is bank quality.
- NIM 4.0% vs MS's 0.7%
- 130.0% NII/revenue growth vs GS's -1.4%
JPM is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 15 yrs, beta 0.94, yield 1.9%
- Lower volatility, beta 0.94, current ratio 0.52x
- PEG 0.81 vs MS's 1.88
- Lower P/E (14.4x vs 17.9x), PEG 0.81 vs 1.14
GS carries the broadest edge in this set and is the clearest fit for quality and momentum.
- Efficiency ratio 0.3% vs MS's 0.4% (lower = leaner)
- +72.7% vs JPM's +21.8%
- Efficiency ratio 0.3% vs MS's 0.4%
MS is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 11.5%, EPS growth 28.3%
- 8.5% 10Y total return vs GS's 6.7%
- Beta 1.40, yield 1.9%, current ratio 1.17x
- 1.9% yield, 12-year raise streak, vs JPM's 1.9%, (1 stock pays no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 130.0% NII/revenue growth vs GS's -1.4% | |
| Value | Lower P/E (14.4x vs 17.9x), PEG 0.81 vs 1.14 | |
| Quality / Margins | Efficiency ratio 0.3% vs MS's 0.4% (lower = leaner) | |
| Stability / Safety | Beta 0.94 vs GS's 1.60, lower leverage | |
| Dividends | 1.9% yield, 12-year raise streak, vs JPM's 1.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | +72.7% vs JPM's +21.8% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs MS's 0.4% |
VACHU vs JPM vs GS vs MS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
VACHU vs JPM vs GS vs MS — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 3 of 6 categories
GS leads 1 • VACHU leads 0 • MS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM and VACHU operate at a comparable scale, with $280.3B and $0 in trailing revenue. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to GS's 13.7%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $280.3B | $125.1B | $115.0B |
| EBITDAEarnings before interest/tax | -$4M | $81.4B | $24.0B | $26.6B |
| Net IncomeAfter-tax profit | $7M | $57.0B | $17.2B | $16.9B |
| Free Cash FlowCash after capex | -$412,702 | $100.9B | -$47.2B | -$17.9B |
| Gross MarginGross profit ÷ Revenue | — | +60.0% | +47.5% | +57.1% |
| Operating MarginEBIT ÷ Revenue | — | +25.9% | +17.5% | +19.1% |
| Net MarginNet income ÷ Revenue | — | +20.4% | +13.7% | +14.7% |
| FCF MarginFCF ÷ Revenue | — | +36.0% | -37.7% | -15.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -96.4% | +16.0% | +45.8% | +48.9% |
Valuation Metrics
JPM leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 16.0x trailing earnings, JPM trades at a 63% valuation discount to VACHU's 43.1x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs MS's 2.19x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $508M | $896.0B | $337.5B | $341.0B |
| Enterprise ValueMkt cap + debt − cash | $508M | $1.50T | $782.8B | $704.8B |
| Trailing P/EPrice ÷ TTM EPS | 43.06x | 16.00x | 20.71x | 20.98x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 14.40x | 17.93x | 18.00x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.90x | 1.32x | 2.19x |
| EV / EBITDAEnterprise value multiple | — | 18.36x | 32.57x | 26.49x |
| Price / SalesMarket cap ÷ Revenue | — | 3.20x | 2.70x | 2.97x |
| Price / BookPrice ÷ Book value/share | 1.53x | 2.47x | 2.70x | 3.03x |
| Price / FCFMarket cap ÷ FCF | — | 8.88x | — | 7.40x |
Profitability & Efficiency
JPM leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $6 for VACHU. JPM carries lower financial leverage with a 2.60x debt-to-equity ratio, signaling a more conservative balance sheet compared to GS's 4.88x. On the Piotroski fundamental quality scale (0–9), MS scores 7/9 vs VACHU's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.6% | +15.9% | +13.6% | +15.3% |
| ROA (TTM)Return on assets | +2.5% | +1.3% | +1.0% | +1.2% |
| ROICReturn on invested capital | -0.5% | +4.5% | +2.2% | +3.1% |
| ROCEReturn on capital employed | -0.7% | +8.9% | +4.0% | +3.3% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 5 | 5 | 7 |
| Debt / EquityFinancial leverage | — | 2.60x | 4.88x | 4.22x |
| Net DebtTotal debt minus cash | -$182,103 | $599.0B | $445.3B | $363.9B |
| Cash & Equiv.Liquid assets | $182,103 | $343.3B | $164.3B | $111.7B |
| Total DebtShort + long-term debt | $0 | $942.4B | $609.5B | $475.6B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.74x | 0.33x | 0.45x |
Total Returns (Dividends Reinvested)
GS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GS five years ago would be worth $30,053 today (with dividends reinvested), compared to $15,500 for VACHU. Over the past 12 months, GS leads with a +72.7% total return vs JPM's +21.8%. The 3-year compound annual growth rate (CAGR) favors GS at 48.1% vs VACHU's 15.7% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +45.0% | -0.5% | +17.2% | +18.8% |
| 1-Year ReturnPast 12 months | +48.3% | +21.8% | +72.7% | +65.3% |
| 3-Year ReturnCumulative with dividends | +55.0% | +138.2% | +224.8% | +157.5% |
| 5-Year ReturnCumulative with dividends | +55.0% | +118.2% | +200.5% | +154.7% |
| 10-Year ReturnCumulative with dividends | +55.0% | +465.8% | +666.8% | +854.4% |
| CAGR (3Y)Annualised 3-year return | +15.7% | +33.6% | +48.1% | +37.1% |
Risk & Volatility
Evenly matched — VACHU and MS each lead in 1 of 2 comparable metrics.
Risk & Volatility
VACHU is the less volatile stock with a -1.97 beta — it tends to amplify market swings less than GS's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MS currently trades 97.7% from its 52-week high vs VACHU's 77.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -1.97x | 0.94x | 1.60x | 1.40x |
| 52-Week HighHighest price in past year | $20.10 | $337.25 | $1095.89 | $219.16 |
| 52-Week LowLowest price in past year | $10.30 | $262.71 | $609.59 | $128.81 |
| % of 52W HighCurrent price vs 52-week peak | +77.1% | +95.1% | +97.0% | +97.7% |
| RSI (14)Momentum oscillator 0–100 | 51.9 | 59.1 | 57.3 | 62.2 |
| Avg Volume (50D)Average daily shares traded | 1K | 7.0M | 1.9M | 4.5M |
Analyst Outlook
Evenly matched — JPM and MS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: JPM as "Buy", GS as "Hold", MS as "Buy". Consensus price targets imply 5.9% upside for JPM (target: $340) vs -8.5% for GS (target: $973). For income investors, MS offers the higher dividend yield at 1.93% vs GS's 1.56%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $339.75 | $972.70 | $201.25 |
| # AnalystsCovering analysts | — | 61 | 55 | 52 |
| Dividend YieldAnnual dividend ÷ price | — | +1.9% | +1.6% | +1.9% |
| Dividend StreakConsecutive years of raises | — | 15 | 14 | 12 |
| Dividend / ShareAnnual DPS | — | $5.95 | $16.62 | $4.14 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.9% | +3.7% | +1.7% |
JPM leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). GS leads in 1 (Total Returns). 2 tied.
VACHU vs JPM vs GS vs MS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VACHU or JPM or GS or MS a better buy right now?
For growth investors, Morgan Stanley (MS) is the stronger pick with 11.
5% revenue growth year-over-year, versus -1. 4% for The Goldman Sachs Group, Inc. (GS). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VACHU or JPM or GS or MS?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 0x versus Voyager Acquisition Corp Unit at 43. 1x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Morgan Stanley's 1. 88x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — VACHU or JPM or GS or MS?
Over the past 5 years, The Goldman Sachs Group, Inc.
(GS) delivered a total return of +200. 5%, compared to +55. 0% for Voyager Acquisition Corp Unit (VACHU). Over 10 years, the gap is even starker: MS returned +854. 4% versus VACHU's +55. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VACHU or JPM or GS or MS?
By beta (market sensitivity over 5 years), Voyager Acquisition Corp Unit (VACHU) is the lower-risk stock at -1.
97β versus The Goldman Sachs Group, Inc. 's 1. 60β — meaning GS is approximately -181% more volatile than VACHU relative to the S&P 500. On balance sheet safety, JPMorgan Chase & Co. (JPM) carries a lower debt/equity ratio of 3% versus 5% for The Goldman Sachs Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VACHU or JPM or GS or MS?
By revenue growth (latest reported year), Morgan Stanley (MS) is pulling ahead at 11.
5% versus -1. 4% for The Goldman Sachs Group, Inc. (GS). On earnings-per-share growth, the picture is similar: Voyager Acquisition Corp Unit grew EPS 50. 0% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VACHU or JPM or GS or MS?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 0. 0% for Voyager Acquisition Corp Unit — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 0. 0% for VACHU. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VACHU or JPM or GS or MS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Morgan Stanley's 1. 88x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 4x forward P/E versus 18. 0x for Morgan Stanley — 3. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JPM: 5. 9% to $339. 75.
08Which pays a better dividend — VACHU or JPM or GS or MS?
In this comparison, MS (1.
9% yield), JPM (1. 9% yield), GS (1. 6% yield) pay a dividend. VACHU does not pay a meaningful dividend and should not be held primarily for income.
09Is VACHU or JPM or GS or MS better for a retirement portfolio?
For long-horizon retirement investors, Voyager Acquisition Corp Unit (VACHU) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -1.
97)). The Goldman Sachs Group, Inc. (GS) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VACHU: +55. 0%, GS: +666. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VACHU and JPM and GS and MS?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: VACHU is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; GS is a large-cap quality compounder stock; MS is a large-cap quality compounder stock. JPM, GS, MS pay a dividend while VACHU does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.